Local NewsBusiness Regulus Therapeutics Announces Completion of Enrollment in First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) By Digital AIM Web Support - February 10, 2021 FacebookTwitterPinterestWhatsApp Like this:Like Loading... Related Featured Local Savings Featured Local Savings